BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Insight

Keeping An Eye And Ear On Patients’ Needs: Where AI Meets Supply Chain

“We want every patient to be able to get the medicines they need when they need them,” says Teresa Rodó, Merck Head of Global Healthcare...

August 11, 2021 | News

Varigard Tech, Proven to Prevent the Tactile Spread of SARS-CoV-2, B.1.617.2 - DELTA Variant

Varigard and Synergy Laboratories have announced the test results of an advanced hand sanitizing gel and surface disinfectant. The test results illustrated...

August 04, 2021 | News

Optical Imaging Facilitates Key Neurological Disease Research

Despite vast amounts of research into neurological diseases, most cannot be cured and only some have therapeutics available. These treatments either slow d...

July 29, 2021 | News

Oncology Drugs to Watch 2021

In this oncology edition of our Drugs to WatchTM series, Clarivate experts explore treatment breakthroughs highlighted at the ASCO Annual Meeting...

July 16, 2021 | Analysis

Staying flexible in biomanufacturing with optionality

The biopharma industry offers big rewards – but it poses big risks, too. Rather than fearing the unknown, the concept of optionality can help you bet...

July 15, 2021 | Opinion | By Firman Ghouze, Cytiva, and Uriel Kusiatin, Provista Diagnostics Inc.

Seizing the opportunities from disruptive forces in biopharma

Three key disruptive trends are challenging expectations and re-writing the rules of biopharma. Evonik is not only capitalizing on these opportunitie...

July 15, 2021 | Opinion

Digital Systems Vital for a Rapid Post-COVID-19 Healthcare Systems Recovery

The global outbreak COVID-19 has put healthcare systems across the globe under tremendous pressure and underscored the urgent need to advance to a smart he...

July 14, 2021 | News

Transformation is never complete

Katrin Kasper of Kasper Kommunikation spoke with our CIO Stefan Henkel about the digital transformation at Siemens Healthineers. ...

July 13, 2021 | Opinion

Testing and Tenacity During the Pandemic : Attilio Focarete

Now, more than a year has passed since Attilio Focarete, Managing Director for Italy, Spain and Portugal at PerkinElmer, who, with his teams, witnessed thi...

July 09, 2021 | Opinion

Improving Productivity and Relevance in Early Drug Discovery

Drug discovery is an expensive, slow, and risky endeavor, with many clinical trials failing at the final hurdle. Maintaining R&D productivity at a sust...

July 06, 2021 | Opinion

Cell and Gene Therapy: A Multifaceted Approach

The active research in these areas not only encompasses laboratory bench work and imaging; it increasingly involves advanced computational methods in image...

July 02, 2021 | Opinion

Infographics : 5 things to consider when choosing your medical packaging

...

June 24, 2021 | News

Malaysia Healthcare & LifeScience review

Risk & Reward Index Industry Rewards 44.4 Industry Risk 80.9 Regional Rank 08 ...

June 17, 2021 | Analysis

What should be the public health priorities in genomics and precision medicine in the next decade

As part of this process, we interviewed nine persons external to CDC from diverse backgrounds and organizations that represent the leading edge of human ge...

June 17, 2021 | Analysis | By Katherine Kolor, Ridgely Fisk Green, and Muin J. Khoury, Office of Genomics and Precision Public Health, Centers for Disease Control and Prevention, Atlanta, Georgia

Stay Connected